Alois Gratwohl

发表

Validation of the EBMT risk score in chronic myeloid leukemia in Brazil and allogeneic transplant outcome.

Daniel Tabak, Afonso Celso Vigorito, Carmino Antonio De Souza, 2005, Haematologica.

Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia.

Augustin Ferrant, Bob Löwenberg, Alois Gratwohl, 2003, The New England journal of medicine.

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.

Francisco Cervantes, Klaus Lechner, Thomas Fischer, 2003, The New England journal of medicine.

A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias.

Sante Tura, Thomas Fischer, Alois Gratwohl, 2002, Blood.

Cytarabine dose for acute myeloid leukemia.

Augustin Ferrant, Bob Löwenberg, Alois Gratwohl, 2011, The New England journal of medicine.

Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

Augustin Ferrant, Alois Gratwohl, Matthias Theobald, 2007, Blood.

One million haemopoietic stem-cell transplants: a retrospective observational study.

Karl Frauendorfer, Alois Gratwohl, Jakob Passweg, 2015, The Lancet. Haematology.

Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.

Medhat Askar, Effie W Petersdorf, Kwang Woo Ahn, 2014, Blood.

NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities.

Alois Gratwohl, W. Wiktor-Jedrzejczak, J. Hofsteenge, 2008, Blood.

Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.

Francisco Cervantes, Alois Gratwohl, Giuseppe Saglio, 2006, Blood.

A survey on cellular and engineered tissue therapies in europe in 2008.

Ivan Martin, Alois Gratwohl, I. Martin, 2010, Tissue engineering. Part A.

Trends of hematopoietic stem cell transplantation in the third millennium

Alois Gratwohl, A. Gratwohl, H. Baldomero, 2009, Current opinion in hematology.

Levels of soluble stem cell factor in serum of patients with aplastic anemia

Alois Gratwohl, A. Gratwohl, A. Tichelli, 1993 .

Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia.

Stefan W Krause, Alois Gratwohl, Claudia Haferlach, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia.

Francisco Cervantes, Thomas Fischer, Alois Gratwohl, 2006, The New England journal of medicine.